EUVIMEDEUVIMED entdecken
Crossref

Meat Hydrolysates Inhibited Dipeptidyl Peptidase‐IV Activity In Vitro Model

Shinichi Takenoyama, Kumiko Kawakita, Toyoo Nakamura, Michio Muguruma

Animal Science Journal · 2026-01 · 97 (1)

DOI: 10.1111/asj.70202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Science Journal, online erschienen am 22.06.2026. Verfasst von Shinichi Takenoyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Nutrition, Minami Kyushu University, Miyazaki, Japan. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Meat, Protein Hydrolysates, Dipeptidyl Peptidase 4. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Ito Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inhibitory activity of dipeptidyl peptidase‐IV (DPP‐IV), an enzyme involved in the suppression of blood glucose elevation, was evaluated using various meat hydrolysates and chicken meat hydrolysate pellet (CMP). Hydrolysates prepared from beef, pork, and chicken by digestion with the food‐grade enzyme Protamex for 90 min exhibited approximately 70% DPP‐IV inhibitory activity. The IC 50 values for DPP‐IV inhibition were 3.2, 3.4, and 3.9 mg/mL for beef, pork, and chicken hydrolysates, respectively. Solutions containing chicken hydrolysate tablets demonstrated concentration‐dependent inhibitory activity, with a fivefold diluted solution still showing high inhibition of over 80%. The IC 50 value of CMP was 3.3 mg/mL, indicating that inhibitory activity was retained following hydrolysis, spray‐drying, and tableting. The fraction with a molecular weight ≤ 3000 Da, which accounts for 65% of the chicken meat hydrolysate tablets, was enriched in peptides with potent blood glucose–regulating and blood pressure–lowering activities. This study demonstrated that food‐derived meat hydrolysates possess DPP‐IV inhibitory activity associated with blood glucose regulation. Chicken meat hydrolysate products, developed as functional peptide powders and tablets with adjusted protein content, exhibit high digestibility and absorption, as well as antioxidant, anti‐fatigue, blood pressure–lowering, and blood glucose‐regulating effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidase IV InhibitorsMeatProtein HydrolysatesDipeptidyl Peptidase 4AnimalsChickensHydrolysisCattleSwineTabletsBlood GlucoseBioactive Peptides, DietaryDose-Response Relationship, DrugInhibitory Concentration 50

Stichwörter der Autor:innen

DPP‐IV inhibitory activitydiabetesfunctional peptidesmeat hydrolysates

Substanzen

Dipeptidyl-Peptidase IV InhibitorsProtein HydrolysatesDipeptidyl Peptidase 4TabletsBlood GlucoseBioactive Peptides, Dietary

Autor:innen und Institutionen

  • Faculty of Health and Nutrition, Minami Kyushu University, Miyazaki, Japan.
  • Marunaka Foods Inc., Ibaraki, Japan.

Förderung

  • Ito Memorial Foundation

Zitieren

APA

Takenoyama, S., Kawakita, K., Nakamura, T., & Muguruma, M. (2026). Meat Hydrolysates Inhibited Dipeptidyl Peptidase‐IV Activity In Vitro Model. Animal Science Journal, 97(1). https://doi.org/10.1111/asj.70202

Vancouver

Takenoyama S, Kawakita K, Nakamura T, Muguruma M. Meat Hydrolysates Inhibited Dipeptidyl Peptidase‐IV Activity In Vitro Model. Animal Science Journal. 2026;97(1). doi:10.1111/asj.70202

BibTeX
@article{Takenoyama2026,
  author = {Takenoyama, Shinichi and Kawakita, Kumiko and Nakamura, Toyoo and Muguruma, Michio},
  title = {Meat Hydrolysates Inhibited Dipeptidyl Peptidase‐IV Activity In Vitro Model},
  journal = {Animal Science Journal},
  year = {2026},
  volume = {97},
  number = {1},
  doi = {10.1111/asj.70202}
}
Kostenlos starten →